An acetyltransferase assay for CREB-binding protein based on reverse phase–ultra-fast liquid chromatography of fluorescent histone H3 peptides
- 1 October 2015
- journal article
- Published by Elsevier in Analytical Biochemistry
- Vol. 486, 35-37
Abstract
No abstract availableKeywords
Funding Information
- Institut National Du Cancer (2012-1-PL-BIO 2012)
- ITMO Cancer
This publication has 14 references indexed in Scilit:
- 50 years of protein acetylation: from gene regulation to epigenetics, metabolism and beyondNature Reviews Molecular Cell Biology, 2014
- Differences in Specificity and Selectivity Between CBP and p300 Acetylation of Histone H3 and H3/H4Biochemistry, 2013
- Transcriptional/epigenetic regulator CBP/p300 in tumorigenesis: structural and functional versatility in target recognitionCellular and Molecular Life Sciences, 2013
- SIRT7 links H3K18 deacetylation to maintenance of oncogenic transformationNature, 2012
- Inactivating mutations of acetyltransferase genes in B-cell lymphomaNature, 2011
- CREBBP mutations in relapsed acute lymphoblastic leukaemiaNature, 2011
- Fluorescent reporters of the histone acetyltransferaseAnalytical Biochemistry, 2008
- Assays for mechanistic investigations of protein/histone acetyltransferasesMethods, 2005
- A rapid and sensitive assay for histone acetyl-transferase activityNucleic Acids Research, 1998
- Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBPNature, 1995